Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments, acted as lead investor in the $26...
Eyenuk’s $26 Million Series A Financing Round
Material Newborn Health Innovations’ $26 Million Financing Round
Foley & Lardner LLP represented AXA IM Alts on the deal. AXA IM Alts, a global leader in alternative investments with over $190 billion of assets...
CXL Ophthalmics’ $32 Million Series A Round of Fundraising
Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts. CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive...
AXA IM Alts’ £1 Billion Development of London skyscraper
Bryan Cave Leighton Paisner has advised AXA IM Alts on the deal. AXA IM Alts, the asset management arm of the French multinational insurance company AXA,...
AXA’s Lease of Office Space in the “Taurus” Building
DLA Piper has advised AXA IM Alts on the lease. AXA IM Alts announced the lease of more than 10,000 sqm office space in the building...
Axa and Swiss Life Asset Managers’ €2 Billion Acquisition of Lyntia Networks
Uría Menéndez advised investment manager Axa and Swiss Life Asset Managers on the deal. Axa, a global leader in alternative investments, and Swiss Life Asset Managers announced the...